Please login to the form below

Not currently logged in

PR company appoints new UK head

Chamberlain Healthcare Public Relations has appointed Mark John Cater as managing director of its London office

Chamberlain Healthcare Public Relations, an inVentiv Health company, has appointed Mark John Cater as managing director of its London office.

Prior to joining Chamberlain, Cater was regional director, Europe, Middle East, Africa and India for Cohn & Wolfe, and chief executive officer of GCI UK before the company merged in 2008 with Cohn & Wolfe. He also spent six years in various leadership roles as partner and director at public relations agency Ketchum, where he was responsible for the company's worldwide healthcare practice and served in both the London and New York offices.  

"Given our brief tenure but serious intentions in London, it is important we attract the best leadership," said Richard Chamberlain, the agency's president. "Mark's 22 years of public relations experience in both the public and private sectors across the UK, European and the US markets makes him exceptionally qualified to lead our London team, support our worldwide clients and further our global communications efforts." 

Chamberlain Healthcare Public Relations serves the healthcare sector exclusively. Operating in London since 2008, the firm works on behalf of several US-based, worldwide pharmaceutical clients on their global brands and issues.


4th January 2010


Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Anthill is a specialist digital sales presentations agency dedicated to enabling life science companies realize effective sales communication through technology....

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...